Predicting in vivo escape dynamics of HIV-1 from a broadly neutralizing antibody

13Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Broadly neutralizing antibodies are promising candidates for treatment and prevention of HIV-1 infections. Such antibodies can temporarily suppress viral load in infected individuals; however, the virus often rebounds by escape mutants that have evolved resistance. In this paper, we map a fitness model of HIV-1 interacting with broadly neutralizing antibodies using in vivo data from a recent clinical trial. We identify two fitness factors, antibody dosage and viral load, that determine viral reproduction rates reproducibly across different hosts. The model successfully predicts the escape dynamics of HIV-1 in the course of an antibody treatment, including a characteristic frequency turnover between sensitive and resistant strains. This turnover is governed by a dosage-dependent fitness ranking, resulting from an evolutionary trade-off between antibody resistance and its collateral cost in drug-free growth. Our analysis suggests resistance–cost tradeoff curves as a measure of antibody performance in the presence of resistance evolution.

Cite

CITATION STYLE

APA

Meijers, M., Vanshylla, K., Gruell, H., Klein, F., & Lässig, M. (2021). Predicting in vivo escape dynamics of HIV-1 from a broadly neutralizing antibody. Proceedings of the National Academy of Sciences of the United States of America, 118(30). https://doi.org/10.1073/pnas.2104651118

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free